Glaxo, Danone Probe Highlights Challenges in China

July 3 (Bloomberg) -- China’s probes of GlaxoSmithKline and Danone highlight challenges for foreign companies in a market where they may be a bigger “prize” for regulators seeking to allay concerns that medicines and foods are unsafe. Stephen Engle reports on Bloomberg Television's "First Up." (Source: Bloomberg)

Most Recent Videos

Shake Shack's Secret Ingredient Is Hospitality: Knapp
22:28 - Jan. 30 -- Malcolm Knapp, president of Malcolm Knapp Inc., and Bloomberg Intelligence's Jennifer Bartashus discuss Shake Shack's IPO and expansion with Bloomberg's Alix Steel on "Street Smart."
  • White House Briefing: Romney, Russia Sanctions, U.S. GDP
  • NFL's Goodell Says Season Has Been Personally Tough
  • FXCM Adopts Shareholder Plan to Block Unwanted Takeovers